Evidence has recently accumulated on ANGPTL8 as a potential marker of NAFLD, metabolic dysfunction and the hypoxic damage related to obstructive sleep apnea syndrome (OSAS) [23–25]. The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatotic liver disease.